Prostate Cancer - Results from #20

Association of Patient and Imaging-Related Factors with False Negative MRI-Targeted Prostate Biopsies of Suspicious PI-RADS 4 and 5 Lesions. May 11, 2022

Radiation therapy compared to radical prostatectomy as first-line definitive therapy for patients with high-risk localised prostate cancer: An updated systematic review and meta-analysis. May 11, 2022

Prostate-Centric Versus Bony-Centric Registration in the Definitive Treatment of Node-Positive Prostate Cancer with Simultaneous Integrated Boost: A Dosimetric Comparison. May 11, 2022

Prostate-Specific Membrane Antigen as Target for Neuroimaging of Central Nervous System Tumors. May 11, 2022

Creation and validation of the harmonized Arabic version of the Expanded Prostate Cancer Index Composite for Clinical Practice (EPIC-CP). May 11, 2022

Detection of failure patterns using advanced imaging in patients with biochemical recurrence following low-dose-rate brachytherapy for prostate cancer. May 10, 2022

Assessment and Management of Cognitive Function in Patients with Prostate Cancer Treated with Second-Generation Androgen Receptor Pathway Inhibitors. May 10, 2022

Joint association of statins and testosterone replacement therapy with cardiovascular disease among older men with prostate cancer: SEER-Medicare 2007-2015. May 10, 2022

Regular, Long-Duration Multivitamin Use and Risk of Overall and Aggressive Prostate Cancer in the Health Professionals Follow-Up Study. May 10, 2022

Exploring Variation in the Receipt of Recommended Active Surveillance for Men with Favorable-Risk Prostate Cancer. May 10, 2022

A meta-analysis on the use of radiotherapy after prostatectomy: adjuvant versus early salvage radiation. May 9, 2022

68Ga-PSMA-11 PET/MRI in patients with newly diagnosed intermediate or high-risk prostate adenocarcinoma: PET findings correlate with outcomes after definitive treatment. May 9, 2022

PARP Inhibition, a New Therapeutic Avenue in Patients with Prostate Cancer. May 9, 2022

Genomic analysis and long-term outcomes of a phase 1 clinical trial on cytoreductive radical prostatectomy. May 9, 2022

SNPs at SMG7 associated with time from biochemical recurrence to prostate cancer death. May 9, 2022

Disparities in the Utilization of Radiation Therapy for Prostate Cancer in the United States: A Comprehensive Review. May 6, 2022

Impact of age on treatment response in men with prostate cancer treated with radiotherapy. May 6, 2022

Imaging Biomarkers in Prostate Stereotactic Body Radiotherapy: A Review and Clinical Trial Protocol. May 6, 2022

Real-world first-line systemic therapy patterns in metastatic castration-resistant prostate cancer. May 6, 2022

Immune Biomarkers in Metastatic Castration-resistant Prostate Cancer. May 6, 2022

Page 2 of 1222

email news signup